本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Propanc Biopharma, Inc.

0.4699
-0.0288-5.78%
成交量:15.58萬
成交額:7.34萬
市值:461.96萬
市盈率:-0.03
高:0.4986
開:0.4974
低:0.4610
收:0.4987
52周最高:49.25
52周最低:0.4600
股本:983.11萬
流通股本:981.82萬
量比:0.99
換手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-17.6157
每股收益(LYR):-371.2241
淨資產收益率:-161.86%
總資產收益率:-70.14%
市淨率:0.49
市盈率(LYR):0.00

資料載入中...

2026/10/05

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/09/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/07/17

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/07/14

重要事件披露

Form 8-K - Current report
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/16

SEC問詢函

Form CORRESP - Correspondence
2026/04/10

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/20

SEC問詢函

Form CORRESP - Correspondence
2026/02/19

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/17

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/13

SEC問詢函

Form CORRESP - Correspondence
2026/02/11

SEC問詢函

Form CORRESP - Correspondence
2026/02/02

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/01/07

重要事件披露

Form 8-K - Current report
2026/01/07

SEC問詢函

Form CORRESP - Correspondence
2025/12/30

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/10/14

重要事件披露

Form 8-K - Current report